Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123858803 | 12385880 | 3 | F | 200303 | 20160816 | 20160519 | 20160822 | PER | US-PFIZER INC-2016264945 | PFIZER | 73.00 | YR | F | Y | 0.00000 | 20160822 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123858803 | 12385880 | 1 | PS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, ONE CAPSULE BY MOUTH A DAY | 20998 | 200 | MG | CAPSULE, HARD | |||||||
| 123858803 | 12385880 | 2 | SS | CELEBREX | CELECOXIB | 1 | 20998 | CAPSULE, HARD | |||||||||||
| 123858803 | 12385880 | 3 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 0.625 MG, ONE TABLET BY MOUTH DAILY | 0 | .625 | MG | TABLET | |||||||
| 123858803 | 12385880 | 4 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | UNK | 0 | TABLET | ||||||||||
| 123858803 | 12385880 | 5 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Oral | 10 MG, ONE TABLET BY MOUTH DAILY | 0 | 10 | MG | TABLET | |||||||
| 123858803 | 12385880 | 6 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | UNK | 0 | TABLET | ||||||||||
| 123858803 | 12385880 | 7 | C | PAROXETINE HCL | PAROXETINE HYDROCHLORIDE | 1 | Oral | 40 MG, ONE TABLET BY MOUTH DAILY | 0 | 40 | MG | TABLET | |||||||
| 123858803 | 12385880 | 8 | C | PAROXETINE HCL | PAROXETINE HYDROCHLORIDE | 1 | UNK | 0 | TABLET | ||||||||||
| 123858803 | 12385880 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG, ONE CAPSULE BY MOUTH DAILY | 0 | 40 | MG | CAPSULE | |||||||
| 123858803 | 12385880 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | 0 | CAPSULE | ||||||||||
| 123858803 | 12385880 | 11 | C | HYDROCODONE/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE | 1 | Oral | [HYDROCODONE 10] / [PARACETAMOL 325], 10/325 ONE TABLET IN THE MORNING, AND ONE TABLET AT NIGHT | 0 | 1 | DF | TABLET | BID | ||||||
| 123858803 | 12385880 | 12 | C | HYDROCODONE/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE | 1 | UNK | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123858803 | 12385880 | 1 | Arthralgia |
| 123858803 | 12385880 | 2 | Pain in extremity |
| 123858803 | 12385880 | 3 | Hysterectomy |
| 123858803 | 12385880 | 5 | Asthma |
| 123858803 | 12385880 | 7 | Depression |
| 123858803 | 12385880 | 9 | Gastrooesophageal reflux disease |
| 123858803 | 12385880 | 10 | Constipation |
| 123858803 | 12385880 | 11 | Back pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123858803 | 12385880 | Arthralgia | |
| 123858803 | 12385880 | Bone pain | |
| 123858803 | 12385880 | Drug dose omission |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123858803 | 12385880 | 1 | 2003 | 0 | ||
| 123858803 | 12385880 | 3 | 198302 | 0 | ||
| 123858803 | 12385880 | 4 | 198302 | 0 | ||
| 123858803 | 12385880 | 5 | 201109 | 0 | ||
| 123858803 | 12385880 | 6 | 201109 | 0 | ||
| 123858803 | 12385880 | 7 | 1998 | 0 | ||
| 123858803 | 12385880 | 8 | 1998 | 0 | ||
| 123858803 | 12385880 | 9 | 2014 | 0 | ||
| 123858803 | 12385880 | 10 | 2014 | 0 | ||
| 123858803 | 12385880 | 11 | 1998 | 0 | ||
| 123858803 | 12385880 | 12 | 1998 | 0 |